GlassScriptPhysician profile
Danielle Marie Molina
NPI 1457888976
$12,374.12
in general payments reported to CMS, 2019-2025
20 companies · $2,668 in 2025
The $2,668 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $596 · 2022: $2,948 · 2023: $1,753 · 2024: $4,408 · 2025: $2,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,292 · Travel and Lodging: $519 · Entertainment: $18.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,292.06 |
| Travel and Lodging | $519.48 |
| Entertainment | $18.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,584.64 | 2021-2025 | Eterna, Proclaim, Octrode |
| Saluda Medical Americas, INC. | $1,987.49 | 2022-2025 | Evoke, Evoke Scs |
| Nalu Medical, INC. | $1,554.40 | 2022 | |
| Curonix LLC | $734.29 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $533.47 | 2022 | |
| Vertos Medical, INC. | $271.48 | 2022-2024 | Mild Device Kit |
| Stryker Corporation | $142.74 | 2022 | |
| Boston Scientific Corporation | $120.14 | 2025 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.88 | 2021 | |
| Biodelivery Sciences International, INC. | $59.05 | 2021 | |
| Collegium Pharmaceutical, INC. | $55.64 | 2021 | |
| Virtus Pharmaceuticals LLC | $39.45 | 2021 | |
| Allergan, INC. | $37.31 | 2021 | |
| Foundation Fusion Solutions, LLC | $31.20 | 2024-2025 | |
| Corium, LLC | $28.64 | 2025 | Azstarys |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25.75 | 2024 | |
| Novo Nordisk INC | $24.91 | 2023 | Rybelsus, Ozempic |
| Spr Therapeutics, INC | $19.13 | 2022 | |
| Almatica Pharma LLC | $18.41 | 2021 | |
| Amgen INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Molina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.